S1P4 Regulates Passive Systemic Anaphylaxis in Mice but Is Dispensable for Canonical IgE-Mediated Responses in Mast Cells
暂无分享,去创建一个
[1] D. Metcalfe,et al. Mast cells signal their importance in health and disease. , 2018, The Journal of allergy and clinical immunology.
[2] C. Heidecke,et al. S1P Signalling Differentially Affects Migration of Peritoneal B Cell Populations In Vitro and Influences the Production of Intestinal IgA In Vivo , 2018, International journal of molecular sciences.
[3] B. Brüne,et al. Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation , 2017, Mediators of inflammation.
[4] S. Valitutti,et al. IL‐33 fine tunes mast cell degranulation and chemokine production at the single‐cell level , 2017, The Journal of allergy and clinical immunology.
[5] H. Germain,et al. Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data , 2017, Scientific Reports.
[6] R. Geha,et al. IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells. , 2016, The Journal of allergy and clinical immunology.
[7] F. Liew,et al. Interleukin-33 in health and disease , 2016, Nature Reviews Immunology.
[8] Jia Jia,et al. Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits , 2016, Nature Genetics.
[9] A. Olivera,et al. Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. , 2016, European journal of pharmacology.
[10] S. Nakae,et al. Subcutaneous Allergic Sensitization to Protease Allergen Is Dependent on Mast Cells but Not IL-33: Distinct Mechanisms between Subcutaneous and Intranasal Routes , 2016, The Journal of Immunology.
[11] B. Brüne,et al. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells , 2016, The Journal of Immunology.
[12] G. Bandara,et al. Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33 , 2015, European journal of immunology.
[13] Xinzhong Dong,et al. Identification of a mast cell specific receptor crucial for pseudo-allergic drug reactions , 2014, Nature.
[14] J. Girard,et al. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells , 2014, Proceedings of the National Academy of Sciences.
[15] Anne-Kathrin Kienzler,et al. Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis. , 2014, The Journal of allergy and clinical immunology.
[16] M. I. Crespo,et al. Neutrophils Exhibit Differential Requirements for Homing Molecules in Their Lymphatic and Blood Trafficking into Draining Lymph Nodes , 2014, The Journal of Immunology.
[17] Krisztina V. Vukman,et al. Isolation and Culture of Peritoneal Cell-derived Mast Cells , 2014 .
[18] Wei Zhang,et al. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice. , 2013, The Journal of allergy and clinical immunology.
[19] P. Bruni,et al. TGFβ1 evokes myoblast apoptotic response via a novel signaling pathway involving S1P4 transactivation upstream of Rho‐kinase‐2 activation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] F. Finkelman,et al. Rapid polyclonal desensitization with antibodies to IgE and FcεRIα. , 2013, The Journal of allergy and clinical immunology.
[21] A. Olivera,et al. Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset. , 2013, Immunology letters.
[22] K. Austen,et al. Developmental origin and functional specialization of mast cell subsets. , 2012, Immunity.
[23] B. Brüne,et al. Apoptotic tumor cells induce IL‐27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity , 2012, European journal of immunology.
[24] M. Tsai,et al. IgE and mast cells in allergic disease , 2012, Nature Medicine.
[25] J. Cyster,et al. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. , 2012, Annual review of immunology.
[26] M. Lipp,et al. Sphingosine‐1‐phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17‐cell differentiation in a murine model , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] J. Lambris,et al. G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2. , 2011, European journal of pharmacology.
[28] R. Proia,et al. Sphingosine-1-phosphate Lyase Deficiency Produces a Pro-inflammatory Response While Impairing Neutrophil Trafficking* , 2010, The Journal of Biological Chemistry.
[29] H. Kuehn,et al. Measuring Mast Cell Mediator Release , 2010, Current protocols in immunology.
[30] B. Vanhaesebroeck,et al. Btk-dependent Rac activation and actin rearrangement following FcεRI aggregation promotes enhanced chemotactic responses of mast cells , 2010, Journal of Cell Science.
[31] R. Proia,et al. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. , 2010, The Journal of clinical investigation.
[32] E. Crivellato,et al. The mast cell: an evolutionary perspective , 2010, Biological reviews of the Cambridge Philosophical Society.
[33] S. Milstien,et al. Essential roles of sphingosine-1–phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema , 2010, The Journal of experimental medicine.
[34] T. Moon,et al. Advances in mast cell biology: new understanding of heterogeneity and function , 2010, Mucosal Immunology.
[35] J. O’Shea,et al. Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. , 2009, Immunity.
[36] R. Proia,et al. The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.
[37] S. Milstien,et al. Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. , 2008, Blood.
[38] F. Finkelman. Anaphylaxis: lessons from mouse models. , 2007, The Journal of allergy and clinical immunology.
[39] R. Proia,et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. , 2007, Immunity.
[40] H. Matsuyuki,et al. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. , 2006, Cellular & molecular immunology.
[41] S. Payne,et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells , 2006, Proceedings of the National Academy of Sciences.
[42] Shoko Iwaki,et al. Generation, Isolation, and Maintenance of Rodent Mast Cells and Mast Cell Lines , 2006, Current protocols in immunology.
[43] Christine Tkaczyk,et al. Integrated signalling pathways for mast-cell activation , 2006, Nature Reviews Immunology.
[44] R. Proia,et al. IgE-dependent Activation of Sphingosine Kinases 1 and 2 and Secretion of Sphingosine 1-Phosphate Requires Fyn Kinase and Contributes to Mast Cell Responses* , 2006, Journal of Biological Chemistry.
[45] E. Goetzl,et al. Type 4 sphingosine 1‐phosphate G protein‐coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] Johan Lennartsson,et al. Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit , 2005, Stem cells.
[47] D. Metcalfe,et al. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. , 2004, Blood.
[48] J. Rivera,et al. The ins and outs of IgE-dependent mast-cell exocytosis. , 2004, Trends in immunology.
[49] R. Proia,et al. Transactivation of Sphingosine-1–Phosphate Receptors by FcɛRI Triggering Is Required for Normal Mast Cell Degranulation and Chemotaxis , 2004, The Journal of experimental medicine.
[50] T. Gudermann,et al. The sphingosine 1‐phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13 , 2003, Journal of cellular biochemistry.
[51] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[52] G P Sapkota,et al. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. , 2001, Molecular cell.
[53] J. Kinet,et al. Minimal Requirements for IgE-Mediated Regulation of Surface FcεRI1 , 2001, The Journal of Immunology.
[54] J. P. Hobson,et al. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. , 2000, Blood.
[55] J. P. Hobson,et al. Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface Receptor , 1999, The Journal of Biological Chemistry.
[56] D. Linnekin,et al. Early signaling pathways activated by c-Kit in hematopoietic cells. , 1999, The international journal of biochemistry & cell biology.
[57] M. Lipp,et al. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. , 1998, Genomics.
[58] C. Srikumari,et al. Missense rhodopsin mutation in a family with recessive RP , 1994, Nature Genetics.
[59] Z. Szallasi,et al. Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. , 1993, The Journal of biological chemistry.
[60] D. Katz,et al. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. , 1980, Journal of immunology.
[61] R. Proia,et al. Shaping the landscape: metabolic regulation of S1P gradients. , 2013, Biochimica et biophysica acta.
[62] M. Tsai,et al. Mast cells and immunoregulation/immunomodulation. , 2011, Advances in experimental medicine and biology.
[63] A. Gilfillan,et al. Regulation of mast cell responses in health and disease. , 2011, Critical reviews in immunology.
[64] M. Maceyka,et al. Extracellular and intracellular actions of sphingosine-1-phosphate. , 2010, Advances in experimental medicine and biology.
[65] D. Metcalfe,et al. Amplification mechanisms for the enhancement of antigen-mediated mast cell activation , 2009, Immunologic research.
[66] M. Tsai,et al. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. , 2008, Journal of dermatological science.
[67] J. Bienenstock,et al. Mast cells , 2004, Springer Seminars in Immunopathology.
[68] J. Kinet,et al. Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. , 2001, Journal of immunology.
[69] C. Bronner,et al. Peptidergic pathway in human skin and rat peritoneal mast cell activation. , 1994, Immunopharmacology.
[70] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .